The firm also said that it is looking for marketing partners for its multimarker urine-based prostate cancer test, which was validated in 500 patients.
In an update medical policy, Anthem said it will cover the test every three years for certain patients for whom the test is considered medically necessary.
The test, called CANScript, combines an ex vivo tumor ecosystem with a machine learning algorithm to predict the therapeutic efficacy of cancer drugs.
The results highlight that while some online information about genetic testing for cancer is good, patients and their doctors should view these sources critically.
The workgroup has created standard categories for variant classification and has outlined a process for mitigating classification disagreements among labs.
In Science this week: gene regulation changes linked to human brain evolution, and more.
The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.
Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.
A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.